$ESGH
ESG Inc.

2023 Q4 Form 10-K Financial Statement

#000152013823000465 Filed on October 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $101.9K
YoY Change
Gross Profit $416.3K
YoY Change
Gross Profit Margin
Selling, General & Admin $20.00K $40.00K
YoY Change -20.0%
% of Gross Profit 4.8%
Research & Development $152.8K
YoY Change
% of Gross Profit 36.71%
Depreciation & Amortization $0.00 $260.00
YoY Change 0.0%
% of Gross Profit 0.0%
Operating Expenses $20.00K $37.86K
YoY Change -31.11%
Operating Profit -$17.72K -$37.86K
YoY Change -31.11%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $29.65K
YoY Change
Pretax Income -$20.00K -$37.58K
YoY Change -31.56%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$20.00K -$37.58K
YoY Change -31.56%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 15.47M shares 25.90M shares 15.47M shares
Diluted Shares Outstanding 25.90M shares 15.47M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00K $10.00K
YoY Change -88.89% -88.89%
Cash & Equivalents $342.3K $6.449K $10.00K
Short-Term Investments
Other Short-Term Assets $40.00K $40.00K
YoY Change
Inventory $1.651M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.239M $46.45K $50.00K
YoY Change 2671.63% -46.08% -44.44%
LONG-TERM ASSETS
Property, Plant & Equipment $18.69M $769.00 $0.00
YoY Change 1939212.14% -25.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $24.03M $769.00 $0.00
YoY Change 2493126.45% -25.27%
TOTAL ASSETS
Total Short-Term Assets $2.239M $46.45K $50.00K
Total Long-Term Assets $24.03M $769.00 $0.00
Total Assets $26.27M $47.22K $50.00K
YoY Change 32040.99% -45.83% -44.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.450M $1.000K $0.00
YoY Change 26591.3% -70.29%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.05M $1.000K $0.00
YoY Change 221706.35% -70.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.423M $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $12.05M $1.000K $0.00
Total Long-Term Liabilities $1.423M $0.00 $0.00
Total Liabilities $13.48M $1.000K $0.00
YoY Change 247895.45% -70.29%
SHAREHOLDERS EQUITY
Retained Earnings -$1.225M -$93.95K
YoY Change 1818.08% 66.68%
Common Stock $25.90K $15.47K
YoY Change 67.45% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.523M $46.22K $50.00K
YoY Change
Total Liabilities & Shareholders Equity $26.27M $47.22K $50.00K
YoY Change 32040.99% -45.83% -44.44%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023
OPERATING ACTIVITIES
Net Income -$20.00K -$37.58K
YoY Change -31.56%
Depreciation, Depletion And Amortization $0.00 $260.00
YoY Change 0.0%
Cash From Operating Activities -$20.00K -$39.69K
YoY Change -1.21%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$40.00K -$40.00K
YoY Change
Cash From Investing Activities -$40.00K -$40.00K
YoY Change 3003.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -20.00K -$39.69K
Cash From Investing Activities -40.00K -$40.00K
Cash From Financing Activities 0.000 0.000
Net Change In Cash -60.00K -$79.69K
YoY Change 92.19%
FREE CASH FLOW
Cash From Operating Activities -$20.00K -$39.69K
Capital Expenditures $0.00
Free Cash Flow -$20.00K -$39.69K
YoY Change -4.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001883835
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 pmin Shares Issued For Director Compensations
SharesIssuedForDirectorCompensations
usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 pmin Common Stock Issued For Services
CommonStockIssuedForServices
usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-08-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-259772
CY2023 dei Entity Registrant Name
EntityRegistrantName
PLASMA INNOVATIVE INC
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-1918342
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
523 School House Rd.
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Kennett Square
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19348
CY2023 dei City Area Code
CityAreaCode
267
CY2023 dei Local Phone Number
LocalPhoneNumber
467-5871
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Public Float
EntityPublicFloat
3094669 usd
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15466668 shares
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6449 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86139 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
40000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
46449 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
86139 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
769 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1029 usd
CY2023Q3 us-gaap Assets
Assets
47218 usd
CY2022Q3 us-gaap Assets
Assets
87168 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3366 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3366 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
3366 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15466668 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15466668 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15466668 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15466668 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
15467 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
15467 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
124700 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
124700 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93949 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56365 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
46218 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
83802 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47218 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87168 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37855 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54953 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
37855 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
54953 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-37855 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-54953 usd
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
271 usd
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
40 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37584 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54913 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-37584 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-54913 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15466668 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15466668 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15466668 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15466668 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
138604 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-54913 usd
CY2022 pmin Shares Issued For Intangible Assets
SharesIssuedForIntangibleAssets
111 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
83802 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-37584 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
46218 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-37584 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-54913 usd
CY2022 pmin Shares Issued For Director Compensations
SharesIssuedForDirectorCompensations
111 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2366 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3366 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
260 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
260 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-11000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39690 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40176 usd
CY2023 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
40000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1289 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1289 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-79690 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-41465 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86139 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127604 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6449 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86139 usd
CY2022 pmin Common Stock Issued For Services
CommonStockIssuedForServices
111 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-37584 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-54913 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93949 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56365 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zokJmvRHOMNh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zWo40X28LSZh">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Although these estimates are based on management’s knowledge of current events and actions management may undertake in the future, actual results may ultimately differ from those estimates and such differences may be material to our consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
6449 usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
86139 usd
CY2023Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
40000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
769 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1029 usd
CY2023 us-gaap Depreciation
Depreciation
260 usd
CY2022 us-gaap Depreciation
Depreciation
260 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15466668 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15466668 shares
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
37584 usd
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
56365 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.21 pure
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7893 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11532 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-7893 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-11532 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
19729 usd
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11836 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19729 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11836 usd

Files In Submission

Name View Source Status
0001520138-23-000465-index-headers.html Edgar Link pending
0001520138-23-000465-index.html Edgar Link pending
0001520138-23-000465.txt Edgar Link pending
0001520138-23-000465-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
image_003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pmin-20220831_10k.htm Edgar Link pending
pmin-20220831_ex31z1.htm Edgar Link pending
pmin-20220831_ex32z1.htm Edgar Link pending
pmin-20230831.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pmin-20230831_def.xml Edgar Link unprocessable
pmin-20230831_cal.xml Edgar Link unprocessable
pmin-20230831_lab.xml Edgar Link unprocessable
pmin-20230831_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pmin-20220831_10k_htm.xml Edgar Link completed